Podcast Series
We Built It Because We Had To
Real conversations with B2B tech founders who built their go-to-market the hard way. Hosted by Jonathan W. Buckley.
View Podcast SiteSubscribe on your favorite platform
Latest Episode
The Immune System Already Works. The Tumor Just Makes Itself Invisible. (George Sens)
LurexBio is developing a non-genetic platform to make immune-cold tumors visible to the immune system, addressing cancers that currently evade detection in 90-95% of cases. George Sens discusses how the company, founded by cancer patient James Clark, is applying tech operator principles to biotech to tackle tumors with survival rates under 13% for pancreatic cancer.
Listen
All Episodes
Investing real money on scale this year?
Get a clear, board-ready read on your go-to-market in two weeks — before you hire the VP, sign the agency, or double the team.
Book a GTM Health Check